News Image

While growth is established for NASDAQ:CORT, the stock's valuation remains reasonable.

By Mill Chart

Last update: Jun 24, 2024

CORCEPT THERAPEUTICS INC (NASDAQ:CORT) has caught the eye of our stock screener as an affordable growth stock. NASDAQ:CORT is displaying robust growth metrics and also excels in terms of profitability, solvency, and liquidity. Additionally, it appears to be reasonably priced. Let's delve into the details.


Affordable growth stocks image

Growth Insights: NASDAQ:CORT

ChartMill assigns a proprietary Growth Rating to each stock. The score is computed by evaluating various growth aspects, like EPS and revenue growth. We take into account the history as well as the estimated future numbers. NASDAQ:CORT was assigned a score of 8 for growth:

  • CORT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.27%, which is quite impressive.
  • CORT shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.48%.
  • The Revenue has been growing by 13.94% on average over the past years. This is quite good.
  • Based on estimates for the next years, CORT will show a very strong growth in Earnings Per Share. The EPS will grow by 26.44% on average per year.
  • The Revenue is expected to grow by 16.69% on average over the next years. This is quite good.
  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Valuation Insights: NASDAQ:CORT

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NASDAQ:CORT has achieved a 6 out of 10:

  • Based on the Price/Earnings ratio, CORT is valued cheaply inside the industry as 82.38% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CORT indicates a somewhat cheap valuation: CORT is cheaper than 77.72% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CORT indicates a somewhat cheap valuation: CORT is cheaper than 78.76% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CORT is valued cheaply inside the industry as 81.87% of the companies are valued more expensively.
  • CORT has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CORT's earnings are expected to grow with 41.92% in the coming years.

Health Insights: NASDAQ:CORT

ChartMill assigns a proprietary Health Rating to each stock. The score is computed by evaluating various liquidity and solvency ratios and ranges from 0 to 10. NASDAQ:CORT was assigned a score of 9 for health:

  • CORT has an Altman-Z score of 20.44. This indicates that CORT is financially healthy and has little risk of bankruptcy at the moment.
  • CORT has a better Altman-Z score (20.44) than 91.71% of its industry peers.
  • There is no outstanding debt for CORT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
  • A Current Ratio of 5.18 indicates that CORT has no problem at all paying its short term obligations.
  • CORT has a better Current ratio (5.18) than 63.73% of its industry peers.
  • CORT has a Quick Ratio of 5.10. This indicates that CORT is financially healthy and has no problem in meeting its short term obligations.
  • CORT's Quick ratio of 5.10 is fine compared to the rest of the industry. CORT outperforms 64.77% of its industry peers.

Profitability Analysis for NASDAQ:CORT

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:CORT scores a 8 out of 10:

  • CORT's Return On Assets of 17.99% is amongst the best of the industry. CORT outperforms 96.89% of its industry peers.
  • The Return On Equity of CORT (21.54%) is better than 91.71% of its industry peers.
  • With an excellent Return On Invested Capital value of 18.83%, CORT belongs to the best of the industry, outperforming 95.34% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CORT is above the industry average of 17.70%.
  • CORT has a better Profit Margin (22.54%) than 93.78% of its industry peers.
  • CORT has a Operating Margin of 23.30%. This is amongst the best in the industry. CORT outperforms 91.19% of its industry peers.
  • The Gross Margin of CORT (98.55%) is better than 99.48% of its industry peers.

More Affordable Growth stocks can be found in our Affordable Growth screener.

Our latest full fundamental report of CORT contains the most current fundamental analsysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

CORCEPT THERAPEUTICS INC

NASDAQ:CORT (12/20/2024, 8:03:39 PM)

After market: 52.55 +1.15 (+2.24%)

51.4

+0.25 (+0.49%)

Follow us for more